Cerulean Pharma reported $6K in Ordinary Share Capital for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Agile Therapeutics AGRX:US $ 0.01M 0M
Arrowhead Research ARWR:US $ 197K 1000
Bayer BAYN:GR € 2515M 0M
Biocept BIOC:US $ 0M 0M
Brainstorm Cell Therapeutics BCLI:US $ 0.01M 0M
Cerulean Pharma CERU:US $ 0.01M 0M
Immunogen IMGN:US $ 2M 0M
Macrogenics MGNX:US $ 0.6M 0M
Nektar Therapeutics NKTR:US $ 0.02M 0M
Perrigo Ordinary Shares PRGO:US $ 7081.7M 19.6M
Seattle Genetics SGEN:US $ 0.18M 0M
YTE INCY:US $ 0.22M 0M